Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications

Drug Discov Today. 2020 Aug;25(8):1431-1443. doi: 10.1016/j.drudis.2020.05.014. Epub 2020 May 31.

Abstract

Prussian blue nanoparticles (PBNPs) are a nanomaterial that presents unique properties and an excellent biocompatibility. They can be synthesized in mild conditions and can be derivatized with polymers and/or biomolecules. PBNPs are used in biomedicine as therapy and diagnostic agents. In biomedical imaging, PBNPs constitute contrast agents in photoacoustic and magnetic resonance imaging (MRI). They are a good adsorbent to be used as antidotes for poisoning with cesium and/or thallium ions. Moreover, the ability to convert energy into heat makes them useful photothermal agents (PAs) in photothermal therapy (PTT) or as nonantibiotic substances with antibacterial properties. Finally, PBNPs can be both reduced to Prussian white and oxidized to Prussian green. A large window of redox potential exists between reduction and oxidation, which result in the enzyme-like characteristics of these NPs.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / toxicity
  • Antidotes / administration & dosage
  • Antidotes / chemistry
  • Antidotes / toxicity
  • Contrast Media / administration & dosage
  • Contrast Media / chemistry
  • Contrast Media / toxicity
  • Ferrocyanides* / administration & dosage
  • Ferrocyanides* / chemistry
  • Ferrocyanides* / toxicity
  • Humans
  • Nanoparticles* / administration & dosage
  • Nanoparticles* / chemistry
  • Nanoparticles* / toxicity
  • Photothermal Therapy

Substances

  • Anti-Bacterial Agents
  • Antidotes
  • Contrast Media
  • Ferrocyanides
  • ferric ferrocyanide